Core Insights - The traditional concept of market hours is becoming obsolete as digital assets trade 24/7, blurring the lines between traditional equities and digital markets [3] - Intercontinental Exchange (ICE) is making significant moves to capture the always-on trading economy, highlighted by its $1 billion investment in Polymarket, which legitimizes prediction markets as a viable asset class [4] - The tokenization of stocks by ICE is not a setback for the crypto market but rather an opportunity for different investment strategies, positioning ICE as a crypto infrastructure investment and Coinbase as a leader in digital derivatives [5] Company Performance - ICE's financial strength is underscored by its ability to fund expansion through cash flows from established businesses, contrasting with startups that often rely on cash burn [6] - In Q3 2025, ICE reported net revenues of $2.4 billion, reflecting a 3% year-over-year increase, and an operating cash flow of $3.4 billion year-to-date [7] Market Positioning - ICE is revitalizing its mortgage technology segment and expanding into decentralized markets to drive future growth [8] - Coinbase has established a strong position in the global crypto derivatives market through strategic acquisitions and subscription service growth, complementing ICE's initiatives [8]

Core Insights - Miami International Holdings, Inc. has sold 90% of its equity in MIAX Derivatives Exchange to a joint venture formed by Robinhood Markets and Susquehanna International Group, retaining a 10% stake in the exchange [1][3] Group 1: Company Strategy and Growth - The sale of MIAXdx aligns with the company's strategy to partner with industry leaders to enhance growth opportunities and unlock value for shareholders [3] - The retained equity stake in MIAXdx allows the company to maintain exposure to the growing prediction market [3] Group 2: Market Position and Operations - MIAXdx is a Designated Contract Market and Derivatives Clearing Organization approved by the Commodity Futures Trading Commission to list and clear fully collateralized futures, options on futures, and swaps [2] - Miami International Holdings operates eight exchanges across various asset classes, including options, futures, equities, and international markets [4]

据报道，德意志交易所集团即将达成一项协议，以约53亿欧元现金加股票的方式收购欧洲基金分销平台 Allfunds Group，最快本周宣布。 据报道，德意志交易所集团即将达成一项协议，以约53亿欧元现金加股票的方式收购欧洲基金分销平台 Allfunds Group，最快本周宣布。 ...

Core Viewpoint - The New York Stock Exchange (NYSE) is developing a blockchain-based trading platform for tokenized securities that will operate 24/7 with instant settlement, marking a significant evolution in market infrastructure [1][2]. Group 1: Platform Development - The NYSE, operated by Intercontinental Exchange (ICE), aims to lead the industry towards fully on-chain solutions, combining advanced trading technology with blockchain post-trade systems [2]. - The new platform will facilitate trading of both tokenized shares of traditional securities and native tokenized securities, enabling investor participation in shareholder dividends and governance [3]. Group 2: Strategic Partnerships and Initiatives - ICE is collaborating with major banking institutions such as BNY and Citi to support the tokenized deposit process and manage fund transfers across its clearinghouses outside traditional banking hours [4]. - The initiative is part of ICE's broader strategy to establish on-chain market infrastructure for trading, settlement, custody, and capital formation in the evolving landscape of global finance [4]. Group 3: Market Trends and Context - Tokenization has emerged as a prominent theme in blockchain, with industry leaders like BlackRock's Larry Fink highlighting it as a major evolution in market infrastructure [6]. - Other companies, such as Robinhood and Coinbase, are also entering the tokenized equity space, indicating a growing trend towards this innovative financial model [6].

Group 1 - Tradeweb Markets Inc. is identified as one of the best depressed stocks to buy currently, with TD Cowen analyst Bill Katz reducing the price target from $140 to $131 while maintaining a "Buy" rating [1] - Barclays has raised its price target on Tradeweb Markets from $121 to $124, keeping an "Equal Weight" rating, indicating a positive outlook ahead of earnings reports [2] - The analyst noted an increase in total volumes across equities, options, and futures quarter-over-quarter, along with a sequential rise in volatility [2] Group 2 - Tradeweb Markets operates electronic marketplaces, and while it shows potential as an investment, certain AI stocks are considered to offer greater upside potential with less downside risk [3]

Group 1 - CME Group plans to launch futures contracts for Cardano, Chainlink, and Stellar on February 9, pending regulatory review [1] - The new products will include standard contracts of 100,000 ADA, 5,000 LINK, and 250,000 XLM, as well as micro contracts at one-tenth the size [1] - Futures allow traders to speculate on future prices without holding the actual tokens, providing institutional investors a compliant way to gain exposure [2] Group 2 - CME's cryptocurrency business experienced 139% year-over-year growth in 2025, with an average daily volume of 278,300 contracts worth $12 billion [3] - The February launch continues CME's expansion into alternative cryptocurrencies beyond Bitcoin and Ethereum, following the launches of Solana and XRP futures [4] - All three tokens (Cardano, Chainlink, and Stellar) have shown elevated trading activity, with Cardano recording $703 million in 24-hour volume on January 15 [5] Group 3 - The launch of Chainlink futures coincides with Bitwise's launch of a Chainlink ETF on January 14, which competes with Grayscale's existing product [6] - Cardano is developing its ecosystem by ratifying a governance proposal to introduce more stablecoins through a 70 million ADA community fund [6]

Core Insights - CME Group Inc. is a leading derivatives marketplace with a market cap of $95.6 billion, offering a variety of futures and options products across multiple sectors [1] Financial Performance - Analysts expect CME to report a profit of $2.72 per share for Q4 2025, reflecting a 7.9% increase from $2.52 per share in the same quarter last year [2] - For the full fiscal year 2025, EPS is projected to be $11.17, an 8.9% increase from $10.26 in fiscal 2024, with further growth expected to $11.62 in fiscal 2026 [3] Stock Performance - Over the past 52 weeks, CME stock has increased by 17%, underperforming the S&P 500 Index's 19.3% gains but outperforming the Financial Select Sector SPDR Fund's 13.8% gains [4] Recent Earnings Report - On October 22, 2025, CME reported an adjusted EPS of $2.68, exceeding Wall Street's expectations of $2.63, with revenue of $1.54 billion also surpassing forecasts of $1.53 billion [5] Analyst Ratings - The consensus opinion on CME stock is moderately bullish, with a "Moderate Buy" rating from 17 analysts, including five "Strong Buy," two "Moderate Buy," seven "Hold," one "Moderate Sell," and two "Strong Sell" recommendations [6] - The average analyst price target for CME is $292.33, indicating a potential upside of 8.9% from current levels [6]

Group 1 - OTC Markets Group Inc. announced that Bora Pharmaceuticals Co., Ltd. has been added to the OTCQX® Best Market eligible trading list, allowing its shares to trade under the ticker "BORAY" [1] - The inclusion in the OTCQX market enables Bora Pharmaceuticals to efficiently expand its financing channels in the U.S. capital market while maintaining its primary listing in Taiwan [1] - OTCQX requires companies to meet high financial standards and adhere to best corporate governance practices, ensuring compliance with applicable securities laws [1] Group 2 - Jason Paltrowitz, Executive Vice President of OTC Markets Group, expressed that Bora Pharmaceuticals is the first Taiwanese issuer to join the OTCQX market, enhancing its visibility among U.S. investors and showcasing OTCQX's global influence [2] - Bobby Sheng, Chairman of Bora Group, highlighted that this milestone allows for cross-market trading in the U.S. through the Level 1 ADR program, which broadens investment channels for U.S. investors while maintaining liquidity for shareholders [3] - Bora Pharmaceuticals aims to become a truly global enterprise, with over 95% of its revenue coming from markets outside Taiwan, and emphasizes the importance of liquidity, trust, and long-term value creation [3] Group 3 - Bora Pharmaceuticals, established in 2007, is a leading pharmaceutical services company focused on integrating contract research, development, and manufacturing (CDMO) with commercial expertise to accelerate product development and meet global patient needs [4] - The company is actively expanding its R&D and sales infrastructure, focusing on niche and rare disease markets to improve patient quality of life [4] - Bora is committed to innovation and sustainable growth through investments in talent, infrastructure, and biopharmaceutical business expansion, setting new standards in the pharmaceutical and CDMO industries [4]

Group 1 - The article discusses the performance of silver in the commodities market, highlighting recent price movements and market trends [1][2] - It notes that silver prices have shown fluctuations, with specific figures indicating a recent price of 94.99 and 97.99 [1][2] Group 2 - The author, Neils Christensen, has extensive experience in financial reporting, particularly in the Canadian market, which adds credibility to the analysis presented [3] - The article emphasizes the importance of accurate information in financial reporting, although it acknowledges that complete accuracy cannot be guaranteed [4]

Summary of Key Points Core Viewpoint - The total short interest in Nasdaq securities has increased slightly, indicating a growing bearish sentiment among investors as of December 31, 2025 Group 1: Nasdaq Global Market - Short interest in 3,498 Nasdaq Global Market securities totaled 15,183,396,236 shares at the end of December 31, 2025, up from 15,012,659,234 shares in the previous period [1] - The December short interest represents an average of 2.83 days, a decrease from 2.90 days in the prior reporting period [1] Group 2: Nasdaq Capital Market - Short interest in 1,671 securities on The Nasdaq Capital Market totaled 3,382,557,383 shares at the end of December 31, 2025, compared to 3,369,741,795 shares in the previous period [2] - This represents an average daily volume of 1.27 days, slightly down from 1.29 days in the prior reporting period [2] Group 3: Overall Nasdaq Securities - Total short interest in all 5,169 Nasdaq securities reached 18,565,953,619 shares at the December 31, 2025 settlement date, an increase from 18,382,401,029 shares in the previous period [3] - This reflects an average of 2.31 days of daily volume, down from 2.36 days in the prior reporting period [3] Group 4: Short Sale Definition - Open short interest positions reported for each Nasdaq security reflect the total number of shares sold short by all broker/dealers, regardless of their exchange affiliations [4]